OKYO today
$1.40-$0.02 (-1.41%)close Nov 12, 2026Trend
DailyUptrend (starting)
4 hourStrong Bearish
1 hourBearish
15 minBearish
5 minLeaning Bullish
Daily trend turns down below $1.26
Key levels
Resistance$1.53
Resistance$1.42
Support$1.28
Support$1.15
Latest news & SEC filings
ProductOKYO Pharma starts patient enrollment for urcosimod Phase 3 study
All OKYO news →About OKYO Pharma
OKYO Pharma is a clinical-stage biopharmaceutical company developing treatments for inflammatory eye diseases and ocular surface conditions. Its lead candidate, urcosimod, targets neuropathic corneal pain and other corneal and anterior segment diseases, while OK-201 is in earlier development. The company operates in the United States and United Kingdom and has no approved products or product revenue.
Based on the company's 20-F filed Jul 20, 2026.
Nasdaq · Healthcare
OKYO Pharma Ltd (OKYO)
What Is the Price Target for OKYO?
SEPT Low Target
$4.25
SEPT Mid Target
$5.00
SEPT High Target
$5.75
Analyst Consensus
$5.00
Is OKYO a Buy or Sell Right Now?
Thesis
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for OKYO.
Start Free Trial →Is OKYO Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
Analyst Consensus
Fair Value
$5.00
34
Moat Score
NONE
4/9
Piotroski Score
-58.9
Altman Z-Score
What Is Smart Money Doing with OKYO?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| CERRONE GABRIELE M | director 10% owner | Buy | 300,000 | $516K | Jun 8, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →OKYO Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
-19900%
FCF Growth YoY
80.9%
Revenue Trend
UNKNOWN
Dark Pool Trades for OKYO
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for OKYO, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 15:16:03 | $1.38 | 2,000 | $$3K | SELL |
| 15:15:12 | $1.41 | 2,875 | $$4K | BUY |
| 14:31:23 | $1.33 | 2,000 | $$3K | SELL |
| 15:10:35 | $1.36 | 5,235 | $$7K | BUY |
| 21:27:09 | $1.38 | 3,750 | $$5K | BUY |
5 dark pool trades shown · $$22K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for OKYO Pharma Ltd (OKYO) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →OKYO — frequently asked questions
What is OKYO stock price today?
OKYO Pharma Ltd (OKYO) is at $1.40, down 1.41% (-$0.02) at the Nov 12, 2026 close.
Why is OKYO stock moving today?
Latest OKYO news — Oct 6, 2026: OKYO Pharma starts patient enrollment for urcosimod Phase 3 study
What is the OKYO price target?
The average analyst price target for OKYO is $5.00, ranging from $5 to $5, based on 1 analysts. Latest: HC Wainwright & Co. maintains on Jul 13, 2026.
What do analysts rate OKYO?
Analyst ratings for OKYO: 0 Buy, 1 Hold, 0 Sell — consensus Hold.
Does OKYO pay a dividend?
OKYO does not currently pay a dividend.
How much debt does OKYO have?
OKYO Pharma Ltd reported $0M of debt and $2M of cash (Mar 31, 2025).
What are OKYO support and resistance levels?
Support: $1.28, $1.15, $1.03. Resistance: $1.42, $1.53, $1.65.
What are insiders doing with OKYO?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on OKYO?
Oct 6, 2026: OKYO Pharma starts patient enrollment for urcosimod Phase 3 study